Insurance

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

A strategic partnership used deep learning AI to boost insurance leads by 32% and win major French awards. Here's how they did it.

Insurtech firm PolicyStreet launches its largest promo yet, offering deep discounts and flexible payments to challenge traditional insurers in Malaysia.

As India's electric scooter sales surge, one insurer is shifting focus from policies to service, aiming to build trust with a new generation of riders.

SCAN Health Plan awards MemorialCare its highest honor, signaling superior quality for over 1.9 million seniors in a competitive Southern California market.

Inszone Insurance continues its rapid expansion by acquiring a 50-year-old agency, gaining deep expertise in the booming event and specialty insurance market.

A new multiyear pact between Envision Healthcare and BCBS of Arizona ends uncertainty, ensuring stable in-network access to critical medical services.

AM Best has reaffirmed CompSource Mutual's 'A (Excellent)' rating. What does this top-tier financial grade mean for Oklahoma's businesses and workers?

Mount Logan Capital offers shareholders a 14% premium in a $15M tender offer, signaling confidence despite mixed financials and a complex market identity.

A new multi-million dollar partnership highlights how AI and automation are radically transforming the insurance industry's outdated payment systems.

Purina Foundation's 2025 grants extend beyond animal welfare, funding disaster relief, youth education, and veteran support in a strategic philanthropic push.

Verisk terminates its $2.35B AccuLynx acquisition after FTC delays, triggering a $1.5B debt redemption and a potential legal battle with the spurned firm.

Indonesia's Mowilex marks seven years of verified carbon neutrality, pivoting from certificates to permanent infrastructure with major solar power investments.

Chinese insurtech Huize is cutting back on financial reports to focus on strategy, but its latest data shows a complex picture of soaring premiums and slowing new user growth.

A unique partnership brings accessible genetic testing to Boca Raton, using a community race to empower families with critical health knowledge.

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

A new settlement positions a cost-effective alternative to the blockbuster eye drug Eylea for a 2026 U.S. launch, signaling intense market disruption.

A new national scholarship champions medical integrity, yet its founder recently settled a major False Claims Act case, raising complex questions.

Two titans of boat rentals unite, forming a marketplace to reshape water adventure tourism with AI, massive scale, and a focus on the blue economy.

As pharma sells GLP-1s directly to patients, doctors are split on the new model. Is it a lifeline for access or a risk to integrated patient care?